New Haven, United States
Manifest Technologies, founded in 2021, is pioneering the transformation of CNS health through its AI-powered precision neuroscience. Emerging from an academic foundation at Yale University's School of Medicine, the company is spearheaded by distinguished experts in computational neuroimaging and psychiatry. Their innovation focuses on leveraging AI-driven systems to enhance therapeutic development, diagnosis, and treatment for CNS disorders.
Based in the United States, Manifest Technologies is deploying the world's first AI-powered computational neuroimaging system. This technology seeks to quantify neural and symptom data, ensuring the delivery of personalized therapies to patients at optimal times.
The company recently secured Seed Round investment on 28 March 2024, backed by prominent investors including Connecticut Innovations, ATMA Capital, and Kaleida Capital. As a player in the AI industry, Manifest Technologies presents a compelling proposition for investors seeking to engage with groundbreaking advancements in healthcare technology.
